Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy

Circulation Journal

Volumn 71, Issue 6, 2007, Pages 936-940

  Fujino, Tadashi ^a,b   Yamashita, Takeshi ^a   Suzuki, Shinya ^a   Sugiyama, Hiroaki ^a   Sagara, Koichi ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a   Igarashi, Masaki ^b   Yamazaki, Junichi ^b  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

^b TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

Atrial fibrillation; Heart failure; Tachycardia induced cardiomyopathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BRAIN NATRIURETIC PEPTIDE; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASODILATOR AGENT; VERAPAMIL; WARFARIN;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; SYSTOLIC DYSFUNCTION; TACHYCARDIA INDUCED CARDIOMYOPATHY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; JAPAN; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; TACHYCARDIA; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 34249690208     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.936     Document Type: Article

References (29)

1. Phillips E, Levine S. Auricular fibrillation without other evidence of heart disease: A cause of reversible heart failure. Am J Med 1949; 7: 478-489.
2. McLaran CJ, Gersh BJ, Sugrue DD, Hammill SC, Seward JB, Holmes DR Jr. Tachycardia induced myocardial dysfunction: A reversible phenomenon? Br Heart J 1985; 53: 323-327.
3. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, et al. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction. Am J Cardiol 1986; 57: 563-570.
4. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69: 1570-1573.
5. Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: Mechanisms and clinical implications. Pacing Clin Electrophysiol 1996; 19: 95-106.
6. Anselme F, Boyle N, Josephson M. Incessant fascicular tachycardia: A cause of arrhythmia induced cardiomyopathy. Pacing Clin Electrophysiol 1998; 21: 760-763.
7. Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Am J Med 2003; 114: 51-55.
8. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 1997; 29: 709-715.
9. Van Gelder IC, Crijns HJ, Blanksma PK, Landsman ML, Posma JL, Van Den Berg MP, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 1993; 72: 560-566.
10. Shite J, Yokota Y, Yokoyama M. Heterogeneity and time course of improvement in cardiac function after cardioversion of chronic atrial fibrillation: Assessment of serial echocardiographic indices. Br Heart J 1993; 70: 154-159.
11. Edner M, Caidahl K, Bergfeldt L, Darpo B, Edvardsson N, Rosenqvist M. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J 1995; 74: 261-267.
12. Luchsinger JA, Steinberg JS. Resolution of cardiomyopathy after ablation of atrial flutter. J Am Coll Cardiol 1998; 32: 205-210.
13. Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, Ellenbogen KA. Tachycardia-related cardiomyopathy: A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc 2000; 75: 790-795.
14. Rodriguez LM, Smeets JL, Xie B, de Chillou C, Cheriex E, Pieters F, et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993; 72: 1137-1141.
15. Parkash R, Maisel WH, Toca FM, Stevenson WG. Atrial fibrillation in heart failure: High mortality risk even if ventricular function is preserved. Am Heart J 2005; 150: 701-706.
16. Fishberger SB, Colan SD, Saul JP, Mayer JE Jr, Walsh EP. Myocardial mechanics before and after ablation of chronic tachycardia. Pacing Clin Electrophysiol 1996; 19: 42-49.
17. Zupan I, Rakovec P, Budihna N, Brecelj A, Kozelj M. Tachycardia induced cardiomyopathy in dogs: Relation between chronic supraventricular and chronic ventricular tachycardia. Int J Cardiol 1996; 56: 75-81.
18. Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Cheng JJ, et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998; 31: 637-644.
19. Tomita M, Spinale FG, Crawford FA, Zile MR. Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy: Disparity between recovery of systolic versus diastolic function. Circulation 1991; 83: 635-644.
20. LeRoy ER, Wang PJ, Couper GL, Friedman PL. Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia. Am Heart J 1991; 121: 816-819.
21. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure: A study of 390 patients. Circulation 1991; 84: 40-48.
22. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community: A study of all incident cases in Olmsted Country, Minnesota, in 1991. Circulation 1998; 98: 2282-2289.
23. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT): The Department of Veterans Affairs CHF-STAT Investigators. Circulation 1998; 98: 2574-2579.
24. Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 1999; 83: 1544-1547.
25. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920-2925.
26. Koitabashi T, Inomata T, Niwano S, Nishii M, Takeuchi I, Nakano H, et al. Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J 2005; 69: 823-830.
27. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: VI102-VI110.
28. Nerheim P, Briger-Botlin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 2004; 110: 247-252.
29. Pak PH, Nuss HB, Tunin RS, Kaab S, Tomaselli GF, Marban E, et al. Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy. J Am Coll Cardiol 1997; 30: 576-584.